CJC-1295 — The Most Important Growth Hormone Peptide You Need to Understand

CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) — the natural hormone your hypothalamus produces to signal the pituitary gland to release growth hormone. It is one of the most studied peptides in the GH secretagogue category and forms the backbone of the majority of serious growth hormone research protocols in 2026. But there is a critical distinction that confuses almost everyone new to this compound: DAC vs No DAC. Getting this wrong means running a fundamentally different protocol than you intended.

CJC-1295 No DAC Modified GRF 1-29 peptide vial — pulsatile growth hormone releasing peptide
CJC-1295 No DAC (Modified GRF 1-29) from PEPTARA Health — produces natural pulsatile GH release when stacked with Ipamorelin. From $60 per 2mg vial.

The CJC-1295 Confusion — What DAC Actually Means

DAC stands for Drug Affinity Complex — a technology that attaches a reactive chemical group to the CJC-1295 molecule which allows it to covalently bind to albumin (a protein naturally abundant in blood). This albumin binding dramatically extends the half-life of the peptide from approximately 30 minutes to 6–8 days.

The result is two fundamentally different compounds with the same base name:

PropertyCJC-1295 DACCJC-1295 No DAC (Mod GRF 1-29)
Half-life6–8 days~30 minutes
GH release patternSustained bleed (constant elevation)Pulsatile (mimics natural rhythm)
Injection frequencyOnce or twice per week2–3x daily or with each Ipamorelin dose
GH pattern typeUnnatural — constant elevationNatural — peaks and troughs
IGF-1 elevationSustained and significantPulsatile, natural pattern
Best stacked withWorks alone or with GHRPIpamorelin or GHRP-2/6
Price (PEPTARA)From $60From $60

⚠️ Critical Point: CJC-1295 DAC produces a constant, unnaturally sustained GH elevation. Most researchers now prefer CJC-1295 No DAC (Mod GRF 1-29) stacked with Ipamorelin because the resulting pulsatile GH pattern more closely resembles natural physiology — which research suggests produces better long-term outcomes and fewer side effects from receptor desensitisation.

CJC-1295 No DAC + Ipamorelin — The Gold Standard Stack

The CJC-1295 No DAC + Ipamorelin combination has become the dominant GH peptide research protocol for a clear reason: the two peptides work through entirely different but complementary receptor systems, producing a synergistic GH pulse that substantially exceeds what either compound achieves alone.

Why the Combination Is Greater Than the Sum of Its Parts

CJC-1295 No DAC activates GHRH receptors on the pituitary — it tells the pituitary "now is the time to release growth hormone." Ipamorelin activates ghrelin receptors (GHS-R1a) — it mimics the hunger hormone ghrelin, which also powerfully stimulates GH release through a completely separate mechanism. When both signals arrive at the pituitary simultaneously, the resulting GH pulse is 2–10x larger than either compound alone would produce.

CJC-1295 + Ipamorelin peptide stack from PEPTARA Health — synergistic growth hormone releasing combination
CJC-1295 + Ipamorelin Stack from PEPTARA Health — the most popular GH peptide combination in performance research. $80 per bundle, 99%+ purity.

Additionally, Ipamorelin is highly selective for GH release — unlike GHRP-2 and GHRP-6, it does not significantly elevate cortisol or prolactin, making it the cleanest GHRP for long-term use. This selectivity is why the CJC-1295 No DAC + Ipamorelin combination is the preferred starting point for most GH peptide research protocols.

Benefits Observed in Research

Body Composition Improvements

The most consistently documented effect in CJC-1295 research is a shift in body composition — reduction in fat mass concurrent with preservation or increase in lean muscle mass. This is consistent with the known effects of elevated growth hormone and downstream IGF-1 on lipolysis (fat cell breakdown) and anabolic signaling in muscle tissue. Most research subjects notice meaningful body composition changes at 8–12 weeks.

Deep Sleep Enhancement

Growth hormone is predominantly released during slow-wave (deep) sleep. CJC-1295 research subjects consistently report improved sleep quality — particularly an increase in deep sleep stages — often within the first 1–3 weeks of use. This is frequently the first effect subjects notice, even before visible body composition changes.

Recovery Acceleration

Elevated IGF-1 from sustained GH stimulation accelerates muscle repair and connective tissue recovery. Research subjects engaged in resistance training typically report faster recovery between sessions, reduced muscle soreness and the ability to train with higher frequency and volume.

Skin and Collagen Quality

Growth hormone directly stimulates collagen synthesis. Subjects over 40 often notice improvements in skin quality — increased firmness, reduced fine lines and improved overall texture — as a secondary effect of sustained GH elevation over 8–12+ weeks.

Ipamorelin growth hormone releasing peptide from PEPTARA Health — selective GHRP with minimal side effects
Ipamorelin from PEPTARA Health — the cleanest GH-releasing peptide available. From $28 per 2mg vial. Zero cortisol or prolactin elevation.

CJC-1295 Research Protocol Reference

Protocol ElementCJC-1295 No DAC + IpamorelinCJC-1295 DAC
Frequency2–3x daily (each injection)1–2x per week
TimingBefore bed (most critical dose) + AMAny time, once weekly
Cycle length12–24 weeks typical research cycle12–24 weeks
Break period4–8 weeks between cycles4–8 weeks
Best time of dayBefore sleep for GH pulse during deep sleepDay or night

CJC-1295 vs Sermorelin — Which GHRH Peptide Is Better?

Sermorelin is a shorter version of GHRH — the first 29 amino acids of the natural 44-amino acid hormone. CJC-1295 No DAC (also called Mod GRF 1-29) is a modified version of the same 29-amino acid sequence with four amino acid substitutions that protect it from enzymatic degradation.

The practical difference: CJC-1295 No DAC has approximately double the half-life of Sermorelin (30 minutes vs 10–15 minutes) and is more resistant to enzymatic breakdown in blood — making it a more efficient GHRH peptide at equivalent doses. This is why CJC-1295 No DAC has largely replaced Sermorelin in most modern GH peptide research protocols.

Advanced Stacking Options

  • CJC-1295 + Ipamorelin + BPC-157: Add BPC-157 to the GH stack for enhanced connective tissue repair — particularly valuable for athletes with existing injuries
  • CJC-1295 + Ipamorelin + Tesamorelin: For subjects with predominantly visceral fat, adding Tesamorelin (which specifically targets visceral adipose tissue) to the GH stack creates a comprehensive fat loss protocol
  • CJC-1295 + Ipamorelin + NAD+: Combining GH stimulation with cellular energy restoration creates a comprehensive anti-aging and body recomposition protocol highly effective for subjects over 45
Tesamorelin growth hormone releasing hormone peptide — targets visceral fat specifically
Tesamorelin from PEPTARA Health — a GHRH peptide with specific evidence for visceral fat reduction. Excellent addition to CJC-1295 protocols for abdominal fat targeting.

Shop CJC-1295 — DAC & No DAC

Both versions available from $60. Pre-bundled CJC-1295 + Ipamorelin stack from $80. 99%+ purity, COA included, cold-chain from North Carolina.

Shop CJC-1295 →